Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms SC-β cells co-encapsulated with CXCL12(VIC) |
Target |
Action stimulants |
Mechanism SDF-1 stimulants(C-X-C motif chemokine ligand 12 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 1 | Preclinical | United States | 25 Mar 2019 |





